A SHAPE-BASED AND CHEMISTRY-BASED DOCKING METHOD AND ITS USE IN THE DESIGN OF HIV-1 PROTEASE INHIBITORS

被引:35
作者
DESJARLAIS, RL
DIXON, JS
机构
[1] Department of Physical and Structural Chemistry, Smith Kline Beecham Pharmaceuticals, King of Prussia, 19406-0939, PA
关键词
LIGAND DESIGN; MOLECULAR SHAPE; DOCK; DATABASE SEARCHING;
D O I
10.1007/BF00126742
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The program DOCK [1,2] has been used successfully to identify molecules which will bind to a specified receptor [3]. The original method ranks molecules based on their shape complementarity to the receptor site and relies on the chemist to bring the appropriate electrostatic or hydrogen bond properties into the molecular skeletons obtained in the search. This is useful when screening a small database of compounds, where it is not likely that molecules with both the correct shape and electrostatic properties will be found. As large databases are more likely to have redundant molecular shapes with a variety of functionality (e.g., members of a congeneric series), it would be useful to have a method which identities molecules with both the correct shape and functionality. To this end we have modified the DOCK 1.0 method to target user-specified atom types to selected positions in the receptor site. The target sites can be chosen based on structural evidence, calculation or inspection. Targeted-DOCK improves the ability of the DOCK method to find the crystallographically determined binding mode of a ligand. Additionally, targeted-DOCK searches a database of small molecules at 100-1000 times the rate of DOCK 1.0, allowing more molecules to be screened and more sophisticated scoring schemes to be employed. Targeted-DOCK has been used successfully in the design of a novel non-peptide inhibitor of HIV-1 protease.
引用
收藏
页码:231 / 242
页数:12
相关论文
共 38 条
  • [1] ABOLA EE, 1987, CRYSTALLOGRAPHIC DAT, P107
  • [2] CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTER - COMPUTER-BASED SEARCH, RETRIEVAL, ANALYSIS AND DISPLAY OF INFORMATION
    ALLEN, FH
    BELLARD, S
    BRICE, MD
    CARTWRIGHT, BA
    DOUBLEDAY, A
    HIGGS, H
    HUMMELINK, T
    HUMMELINKPETERS, BG
    KENNARD, O
    MOTHERWELL, WDS
    RODGERS, JR
    WATSON, DG
    [J]. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1979, 35 (OCT): : 2331 - 2339
  • [3] PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES
    BERNSTEIN, FC
    KOETZLE, TF
    WILLIAMS, GJB
    MEYER, EF
    BRICE, MD
    RODGERS, JR
    KENNARD, O
    SHIMANOUCHI, T
    TASUMI, M
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) : 535 - 542
  • [4] THE COMPUTER-PROGRAM LUDI - A NEW METHOD FOR THE DENOVO DESIGN OF ENZYME-INHIBITORS
    BOHM, HJ
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1992, 6 (01) : 61 - 78
  • [5] X-RAY CRYSTAL-STRUCTURE OF THE HIV PROTEASE COMPLEX WITH L-700,417, AN INHIBITOR WITH PSEUDO C2 SYMMETRY
    BONE, R
    VACCA, JP
    ANDERSON, PS
    HOLLOWAY, MK
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (24) : 9382 - 9384
  • [6] NONPEPTIDE HIV PROTEASE INHIBITORS DESIGNED TO REPLACE A BOUND WATER
    CHENERA, B
    DESJARLAIS, RL
    FINKELSTEIN, JA
    EGGLESTON, DS
    MEEK, TD
    TOMASZEK, TA
    DREYER, GB
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (12) : 2717 - 2722
  • [7] SOLVENT-ACCESSIBLE SURFACES OF PROTEINS AND NUCLEIC-ACIDS
    CONNOLLY, ML
    [J]. SCIENCE, 1983, 221 (4612) : 709 - 713
  • [8] THE HIV-1 PROTEASE AS A THERAPEUTIC TARGET FOR AIDS
    DEBOUCK, C
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) : 153 - 164
  • [9] USING SHAPE COMPLEMENTARITY AS AN INITIAL SCREEN IN DESIGNING LIGANDS FOR A RECEPTOR-BINDING SITE OF KNOWN 3-DIMENSIONAL STRUCTURE
    DESJARLAIS, RL
    SHERIDAN, RP
    SEIBEL, GL
    DIXON, JS
    KUNTZ, ID
    VENKATARAGHAVAN, R
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (04) : 722 - 729
  • [10] A SYMMETRICAL INHIBITOR BINDS HIV-1 PROTEASE ASYMMETRICALLY
    DREYER, GB
    BOEHM, JC
    CHENERA, B
    DESJARLAIS, RL
    HASSELL, AM
    MEEK, TD
    TOMASZEK, TA
    [J]. BIOCHEMISTRY, 1993, 32 (03) : 937 - 947